Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2003
08/05/2003US6602903 Substituted heterocyclic compounds
08/05/2003US6602902 Dha-pharmaceutical agent conjugates to improve tissue selectivity
08/05/2003US6602900 F-type prostaglandins as ocular hypotensives
08/05/2003US6602898 Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
08/05/2003US6602896 p38MAPK inhibitor and uses thereof
08/05/2003US6602893 Amide derivative of amlodipine
08/05/2003US6602891 Muscarinic receptor agonists
08/05/2003US6602890 N-(3,5-dichloropyridin-4-yl)-2-(1-(4-fluorobenzyl)-5 -hydroxyindol-3-yl)-2-oxoacetamide, for example; treating eosinophil-related conditions, including chronic obstructive pulmonary disease
08/05/2003US6602889 5-heteroaryl substituted indoles
08/05/2003US6602888 Use of α1C specific compounds to treat benign prostatic hyperplasia
08/05/2003US6602887 Chronic, bolus administration of D-threo methylphenidate
08/05/2003US6602883 Inhibitors of farnesyl protein transferase
08/05/2003US6602882 Quinoline derivatives and their use as antibacterial agents
08/05/2003US6602881 Anti-inflammatory uses of manzamines
08/05/2003US6602880 3-phenyl-3,7-diazabicyclo[3.3.1] nonane compounds, process for preparing them, pharmaceutical compositions containing them and use thereof to inhibit cardiac arrhythmia
08/05/2003US6602879 Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases
08/05/2003US6602878 Acylquanidine derivatives, method for preparing same, application as medicines and pharmaceutical compositions containing them
08/05/2003US6602877 Imidazolyl-cyclic acetals
08/05/2003US6602876 Adhesion receptor antagonists
08/05/2003US6602875 Sorbitol dehydrogenase inhibitors
08/05/2003US6602874 5-(2-(4-methylpiperazin-1-yl)-phenyl)- furan-2-carboxylic acid 4-chlorobenzylamide, for example; treating or preventing migraine, depression and other disorders for which a 5-HT1, agonist or antagonist is indicated
08/05/2003US6602872 Substituted pyridazines having cytokine inhibitory activity
08/05/2003US6602871 Thrombin or factor Xa inhibitors
08/05/2003US6602870 Synergistic antitumor mixture of tegafur, uracil and folinic acid to potentiate coadministered oxaliplatin; colorectal cancer
08/05/2003US6602869 Compounds derived from benzoic acid esters, composition containing said compounds and use thereof
08/05/2003US6602868 Administering a heterocyclic amine or a phenylazacycloalkane
08/05/2003US6602867 Triazole compounds with dopamine-D3-receptor affinity
08/05/2003US6602866 Mercaptoacetylamide derivatives, a process for their preparation and their use
08/05/2003US6602865 Pyridazino(4,5-b)(1,5)oxazepinone, -thiazepinone and -diazepinone compounds
08/05/2003US6602864 Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds
08/05/2003US6602863 Irreversible inhibitors of tyrosine kinases
08/05/2003US6602862 1-Amino-alkylcyclohexanes as trypanocidal agents
08/05/2003US6602857 Antisense modulation of PTP1B expression
08/05/2003US6602705 Expression of HIV polypeptides and production of virus-like particles
08/05/2003US6602683 Biologically active Eph family ligands
08/05/2003US6602670 Treating tumors; obtain tissue sample, isolate nucleotide sequences, amplify nucleotide sequences, monitor nucleotide sequence concentration of marker gene, compare to control
08/05/2003US6602664 3′-azido-2′,3′-dideoxyuridine in an anti-HIV effectiveness test protocol
08/05/2003US6602525 Compositions comprising nitrofurantoin and uva ursi
08/05/2003US6602522 Omeprazole for oral administration; avoids need to use a separate or dual coating layer to physically isolate the drug and controls bioavailability by providing cohesiveness of powder upon disintegration
08/05/2003US6602512 L-carnitine and/or at least one alkanoyl L-carnitine and creatinol-phosphate
08/05/2003US6602501 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
08/05/2003US6602496 Applying polymerizable monomer and fungicide; applying to skins
08/05/2003US6602489 Compact hairspray product consisting of hairspray concentrate, container and fine spray pump with pre-pressurization
08/05/2003US6602487 Useful as tests for determining the ability of a chemical compound to inhibit or reduce coronary vasospasms; exposing cells to a combination of serotonin and a thromboxane A2 mimetic (U46619)
08/05/2003US6602296 Chemical supplementation of bone
08/05/2003US6602274 Targeted transcutaneous cancer therapy
08/05/2003US6601580 Enhancing therapeutic effectiveness of nitric oxide inhalation
08/05/2003CA2419989A1 Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents
08/05/2003CA2362917C Methods for anti-tumor therapy
08/05/2003CA2329259C Convection-enhanced delivery of aav vectors
08/05/2003CA2275827C Method for treating glaucoma
08/05/2003CA2275595C Prevention and treatment of skeletal disorder with ep2 receptor subtype selective prostaglandin e2 agonists
08/05/2003CA2272665C Method of treating glaucoma and ischemic retinopathy
08/05/2003CA2264511C Compounds useful for inhibition of farnesyl protein transferase
08/05/2003CA2224412C Composition containing a nerve fibre reactivity modulating compound
08/05/2003CA2125490C Antimetastasis agent of malignant tumors
08/05/2003CA2088798C Condensed imidazopyridine derivatives
08/05/2003CA2087672C 1,5-benzodiazepine derivatives
08/05/2003CA2082934C Phthalocyanatopolyethylene glycol, and phthalocyanato saccharides as fluorescent digoxin reagents
08/05/2003CA2079374C (bicyclic-azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
08/05/2003CA2079373C (azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
08/05/2003CA2075861C Dibenz[b,f][1,4]oxazepin-11(10h)-ones for multidrug resistance reversing agents
08/01/2003CA2418410A1 Novel, water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases
08/01/2003CA2370396A1 Hepatitis c inhibitor tri-peptides
08/01/2003CA2369970A1 Hepatitis c inhibitor tri-peptides
07/2003
07/31/2003WO2003062472A1 Cooperative oligonucleotides
07/31/2003WO2003062443A2 Novel substituted alkane compounds and uses thereof
07/31/2003WO2003062421A1 Bispecific antisense olignucleotides that inhibit igfbp-2 and igfbp-5 and methods of using same
07/31/2003WO2003062414A2 Methods of obtaining isoform specific expression in mammalian cells
07/31/2003WO2003062406A1 Method for the production of resveratrol in cell cultures
07/31/2003WO2003062394A2 Methods and compositions for rna interference
07/31/2003WO2003062392A2 Methods of treating conditions associated with an edg receptor
07/31/2003WO2003062390A2 Compositions and methods for the modulation of sphingolipid metabolism and/or signaling
07/31/2003WO2003062388A2 Inhibition of rna function
07/31/2003WO2003062279A1 Nutraceuticals for the treatment, protection and restoration of connective tissues
07/31/2003WO2003062274A1 Novel proteins and dnas thereof
07/31/2003WO2003062271A1 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof
07/31/2003WO2003062265A2 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
07/31/2003WO2003062262A2 Modulation of heat-shock-protein-based immunotherapies
07/31/2003WO2003062260A1 Triterpene quaternary salts as biologically active surfactants
07/31/2003WO2003062252A1 Edg receptor agonists
07/31/2003WO2003062248A2 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists
07/31/2003WO2003062247A2 Phosphinic pseudo-peptide derivatives for selective inhibition of the active c-terminal site of angiotensin converting enzyme (i) (ace)
07/31/2003WO2003062245A1 Fused bicyclic pyrimidine derivatives
07/31/2003WO2003062242A1 Biocidal compounds and their preparation
07/31/2003WO2003062241A1 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
07/31/2003WO2003062240A1 Pteridine derivatives, method for the production thereof, and use thereof
07/31/2003WO2003062238A1 Tricyclic 2-pyrimidone compounds useful as hiv reverse transcriptase inhibitors
07/31/2003WO2003062236A1 2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d]PYRIMIDIN-7-ONES
07/31/2003WO2003062235A1 Modulators of acetylcholine receptors
07/31/2003WO2003062234A1 Quinoxaline compounds
07/31/2003WO2003062233A1 2-acylaminothiazole derivative or salt thereof
07/31/2003WO2003062231A1 Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones
07/31/2003WO2003062228A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection
07/31/2003WO2003062227A1 Rho-kinase inhibitors
07/31/2003WO2003062225A1 Pyrimidine derivatives as rho-kinase inhibitors
07/31/2003WO2003062220A1 N-oxyde of n-phenyl-2-pyrimidine-amine derivatives
07/31/2003WO2003062214A1 Novel stable crystal of benzylthiazolidinedione derivative and method for preparation thereof
07/31/2003WO2003062211A1 Pyrimidinone viral polymerase inhibitors
07/31/2003WO2003062209A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
1 ... 5387 5388 5389 5390 5391 5392 5393 5394 5395 5396 5397 5398 5399 5400 5401 5402 5403 5404 5405 5406 5407 ... 7860